Increased SLAMF7high Monocytes in Myelofibrosis Patients Harboring JAK2V617F Provide a Therapeutic Target of Elotuzumab.
Takaaki Maekawa,Shoichiro Kato,Toshikuni Kawamura,Kohei Takada,Takehiro Sone,Hiraku Ogata,Keita Saito,Takuya Izumi,Shigeki Nagao,Kosuke Takano,Yosuke Okada,Noriaki Tachi,Masahiro Teramoto,Toshikatsu Horiuchi,Reina Hikota-Saga,Kaori Endo-Umeda,Shigeyuki Uno,Yukiko Osawa,Ayako Kobayashi,Shinichi Kobayashi,Ken Sato,Michihiro Hashimoto,Shinya Suzu,Kensuke Usuki,Soji Morishita,Marito Araki,Makoto Makishima,Norio Komatsu,Fumihiko Kimura Blood（2019）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper